The company has developed the PleuraFlow System, which allows surgeons to select chest tubes that function without clogging, and choose smaller, more minimally invasive tubes to minimize pain. The company has obtained regulatory approval and launched the product. Early commercial experience has allowed us to learn more about anticipated sales cycle, training needs to optimize clinical usage and staffing needs to grow adotpion.